Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cross-population validation of European GWAS loci for metabolic syndrome in Chinese schizophrenia.

BMC psychiatry - 6 May 2026

You Yangyang, Qiao Ning, Chen Yao, Wang Zhou, Zhuang Lirong, Fang Xinyu, Tang Xiaowei, Zhang Xiangrong

Abstract excerpt

BACKGROUND: Long-term use of second-generation antipsychotics (SGAs) increases the risk of metabolic syndrome (MS) in patients with schizophrenia (SCZ). Using susceptibility loci identified by European Genome-Wide Association Study (GWAS) as entry points, we conducted a case-control study to verify their association with antipsychotic-induced MS in Chinese Han SCZ patients. METHODS: Clinical and metabolic data...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to China
Share to East Asian People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Loci

Share to Genome-Wide Association Study

Share to Metabolic Syndrome

Share to Receptors, G-Protein-Coupled

Share to Schizophrenia

Source

Open in PubMed Open full text

Identifiers

PMID: 42092854
DOI: 10.1186/s12888-026-08144-4
PMCID: PMC13330453

Genes

TDRD15
DBP
TG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cross-population validation of European GWAS loci for metabolic syndrome in Chinese schizophrenia.PMID 42092854Read ↗

Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS).Semantic proximity Read ↗

Pharmacogenetic study of antipsychotic–induced lipid and BMI changes in Chinese schizophrenia patients: A Genome-Wide Association StudySemantic proximity Read ↗

Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics.Semantic proximity Read ↗

Pharmacogenetic Study of Antipsychotic-Induced Lipid and BMI Changes in Chinese Schizophrenia Patients: A Genome-Wide Association StudySemantic proximity Read ↗

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian BiobankSemantic proximity Read ↗

Identification of Schizophrenia Susceptibility Loci in the Urban Taiwanese Population.Semantic proximity Read ↗

Shared genetic components between metabolic syndrome and schizophrenia: Genetic correlation using multipopulation data sets.Semantic proximity Read ↗

Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation.Semantic proximity Read ↗

Identifying genetic contributions of 6q21 loci and PPAR pathway to antipsychotic-induced metabolic syndrome: a Sex-Stratified Multi-Omics study.Semantic proximity Read ↗

Prevalence and factors associated of metabolic syndrome in first- treatment drug-naïve schizophrenia patients: a large-scale cross- sectional studySemantic proximity Read ↗

Exploring Lead loci shared between schizophrenia and Cardiometabolic traits.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.